KalVista Pharmaceuticals, Inc. (KALV) › RevenueKalVista Pharmaceuticals, Inc. (KALV) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $2.13M2017: $1.50M2018: $8.39M2024: $50.00M$50.00M2016Revenue (USD)2024Fiscal YearRevenueChange YoY2024$50.00M—2018$8.39M+458.1%2017$1.50M-29.5%2016$2.13M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share